2022-2023 Intensive Course in Community Cancer Genetics and Research Training | Full Spectrum & Workshops ~ Track 1
The increasing demand for genetic cancer risk assessment (GCRA) services has been fueled by the rapid evolution of genetic information and direct-to-consumer marketing by commercial genetic testing vendors.
Identifying hereditary cancer predisposition through genetic cancer risk assessment (GCRA) allows for intensified measures to prevent cancers or detect them at an earlier, more treatable stage. Once delivered primarily through academic health centers, the demand for GCRA services in the community setting is steadily increasing. There is a surge in demand for GCRA services across the nation, but too few clinicians with adequate training to provide GCRA services.
Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in Genetics or Advanced Practice Nurses, and Geneticists.
- Integrate cancer genetics and oncology knowledge into clinical practice.
- Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment and case management process.
- Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemo preventive and surgical interventions.
- Incorporate understanding of medical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration.
- Examine the value of hereditary cancer registries, cancer epidemiology and cancer prevention studies for patients and clinicians.
- Realize greater professional self-efficacy related to genetic cancer risk assessment skills.
- Incorporate web-based resources into ongoing practice-based education, professional development, and research support.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.
As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months. Faculty presenters who are in a position to control the content of an educational activity must identify any real or apparent conflict(s) of interest by disclosing to the Department of CME all relevant financial relationships with any ineligible company, which is defined as any entity whose primary business is to produce, market , sell, re-sell or distribute healthcare products used by or on patients. To comply with more intense scrutiny by accreditation agencies, content whose faculty has disclosed any relevant financial relationships with an ineligible company, have been peer reviewed prior to presenting and any potential conflicts relative to the previous disclosure have been resolved.
Presenters/Planners: Listing of Faculty and respective Disclosures
The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.
CME Committee/Reviewer Nothing to Disclose: Patricia Aoun, MD; Chandana Banerjee, MD; Daneng Li, MD; Anna Pawlowska, MD; Michael Rosenzweig, MD; Crystal Saavedra; Behrouz Salehian, MD; Gagandeep P. Singh, MD; Sepidah Shayani, PharmD; Shanmuga Subbiah, MD
City of Hope further encourages faculty/ authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.
2022-2023 Intensive Course in Community Cancer Genetics and Research Training | Full Spectrum & Workshops ~ Track 1 has received no commercial support.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 89.5AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1™ 89.5
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 89.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 29.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 89.50 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2022-2023 Intensive Course in Community Cancer Genetics and Research Training | Full Spectrum & Workshops ~ Track 1 for a maximum of 89.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 89.50 Attendance
You must be logged in to access this activity.
In order to earn credit for this activity, participants must:
- Read learning objectives and faculty disclosures
- View Enduring/Module Videos
- Participate in Virtual Web Conference Review Sessions
- Complete the Evaluation
- Participate in 5 GCRA Case Conference sessions
- Participate in the Workshops
Upon satisfactory completion, you will have the option to receive a print out of your certificate.
INSTRUCTIONS TO OBTAIN ABIM MOC
Physicians who wish to claim ABIM MOC points for this activity must comply with the instructions noted above to obtain AMA PRA Category 1 Credit™ as well as the following:
- Complete and successfully pass the ABIM MOC Activity Self-Assessment (Part II).
- Minimum passing score of 70% will be required.
- Participants will only have ONE opportunity to pass the Activity Self-Assessment (Part II).
MOC Breakdown will be as follows:
- 2 MOC Points per week for a total of 24 points
- 1 MOC Point per GCRA Case Conference session.
Max amount of ABIM MOC points available: 29.0
Estimated time frame for completion of this activity, including the time to complete the evaluation and post test is 89 and a half hours.